🇺🇸 FDA
Patent

US 6962936

Triazole-derived kinase inhibitors and uses thereof

expired A61PA61P1/16A61P11/00

Quick answer

US patent 6962936 (Triazole-derived kinase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Nov 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P1/16, A61P11/00, A61P17/06, A61P19/08